Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma

Abstract

Concurrent chemoradiotherapy for locoregional recurrent NPC seems promising. The morbidity experienced resulted from locoregional disease with few progressing to develop systemic involvement.